Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer
Clinical trial NCT02953782 · COMPLETED
Trial details
- NCT number
- NCT02953782
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-02
- Primary completion
- 2020-02-10
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.